1. Horlocker T.T., Wedel D.J., Rowlingson J.C., Enneking F.K., Kopp S.L., Benzon H.Tetal. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition) // Reg Anesth Pain Med. – 2010. – JanFeb; 35(1): P.64-101.
2. Bates Sh. M., Greer I.A., Middeldorp S., Veenstra D.L., Prabulos A-M., et al. VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest. – February 2012. – 141: 2 suppl. e691S-e736S.
3. Sénat M.V., Sentilhes L., Battut A., Benhamou D., Bydlowski S., et al. Postpartum practice: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF) // Eur J Obstet Gynecol Reprod Biol. – 2016. – Jul; 202: P.1-8.
4. Afshari A., Ageno W., Ahmed A., Duranteau J., Faraoni D., et al. ESA VTE Guidelines Task Force. European Guidelines on perioperative venous thromboembolism prophylaxis: Executive summary // Eur J Anaesthesiol. – 2018. – Feb; 35(2): P.77-83.
5. Ducloy-Bouthors A.S., Baldini A., Abdul-Kadir R., Nizard J. ESA VTE Guidelines Task Force. European guidelines on perioperative venous thromboembolism prophylaxis: Surgery during pregnancy and the immediate postpartum period // Eur J Anaesthesiol. – 2018. – Feb; 35(2): P.130-133.
6. Kearon C., Akl E.A., Ornelas J., Blaivas A., Jimenez D., et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report // Chest. – 2016. – Feb; 149(2): P.315-352.
7. Bain E., Wilson A., Tooher R., Gates S., Davis L.J., Middleton P. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period // Cochrane Database Syst Rev. – 2014. – Feb; 11(2): CD001689.
8. Royal College of Obstetricians and Gynaecologists. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium Green-top // Guideline No. 37a. – April 2015. – 40p.
9. Rath W., Tsikouras P., von Tempelhoff G.F. Pharmacological Thromboprophylaxis during Pregnancy and the Puerperium: Recommendations from Current Guidelines and their Critical Comparison // Z Geburtshilfe Neonatol. – 2016. – Jun; 220(3): P.95-105.
10. Koenig-Oberhuber V., Filipovic M. New antiplatelet drugs and new oral anticoagulants // Br J Anaesth. – 2016. – Sep; 117suppl. 2: ii74-ii8449.
11. Ormesher L., Simcox L., Tower C., Greer I.A. Management of inherited thrombophilia in pregnancy // Womens Health (Lond). – 2016. – Jul; 12(4): P.41433.
12. Croles F.N., Nasserinejad K., Duvekot J.J., Kruip M.J., Meijer K., et al. Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis // BMJ. – 2017. – Oct 26; 359: j4452.
13. Zhang T., Ye X., Zhu T., Xiao X., Liu Y., et al. Antithrombotic Treatment for Recurrent Miscarriage: Bayesian Network Meta-Analysis and Systematic Review // Medicine (Baltimore). – 2015. – Nov; 94(45): e1732.
14. Ormesher L., Simcox L.E., Tower C., Greer I.A. «To test or not to test», the arguments for and against thrombophilia testing in obstetrics // Obstet Med. – 2017. – Jun; 10(2): P.61-66.
15. Rodger M.A., Gris J.C., de Vries J.I.P., Martinelli .I, Rey É., et al. LowMolecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomized controlled trials // Lancet. – 2016. – Nov 26; 388(10060): P.2629-2641.
16. Duffett L., Rodger M. LMWH to prevent placenta-mediated pregnancy complications: an update // Br J Haematol. – 2015. – Mar; 168(5): P.38-619.
17. Leffert L.R., Dubois H.M., Butwick A.J., Carvalho B., Houle T.T., et al. Neuraxial Anesthesia in Obstetric Patients Receiving Thromboprophylaxis With Unfractionated or Low-Molecular-Weight Heparin: A Systematic Review of Spinal Epidural Hematoma // AnesthAnalg. – 2017. – Jul; 125(1): P.223-231.
18. D’Alton M.E., Friedman A.M., Smiley R.M., Montgomery D.M., Paidas M.J., et al. National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism // AnesthAnalg. – 2016. – Oct; 123(4): P.9-942.
19. Leffert L., Butwick A., Carvalho B., Arendt K., Bates S.M., et al. Members of the SOAP VTE Taskforce. The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the Anesthetic Management of Pregnant and Postpartum Women Receiving Thromboprophylaxis or Higher Dose Anticoagulants // AnesthAnalg. – 2018. – Mar; 126(3): P.928-944.
20. Lagerkranser M. Neuraxial blocks and spinal haematoma: Review of 166 case reports published 1994-2015. Part 1: Demographics and risk-factors // Scand J Pain. – 2017. – Apr; 15: P.118-129.
21. Gonzalez-Fiol A., Eisenberger A. Anesthesia implications of coagulation and anticoagulation during pregnancy // SeminPerinatol. – 2014. – Oct; 38(6): P.7370.
22. Working Party: Association of Anaesthetists of Great Britain & Ire land; Obstetric Anaesthetists’ Association; Regional Anaesthesia UK. Regional anaesthesia and patients with abnormalities of coagulation: the Association of Anaesthetists of Great Britain & Ireland The Obstetric Anaesthetists’ Association Regional Anaesthesia UK // Anaesthesia. – 2013. – Sep; 68(9): P.72-966.
23. Yarrington C.D., Valente A.M., Economy K.E. Cardiovascular Management in Pregnancy: Antithrombotic Agents and Antiplatelet Agents // Circulation. –2015. – Oct 6; 132(14): P.64-135.
24. Shaban A., Moritani T., Al Kasab S., Sheharyar A., S. Limaye K., et al. Spinal Cord Hemorrhage // J Stroke Cerebrovasc Dis. – 2018. – Mar 16.; pii: S10523057(18)30065-X.